These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12097599)

  • 1. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.
    Center RJ; Leapman RD; Lebowitz J; Arthur LO; Earl PL; Moss B
    J Virol; 2002 Aug; 76(15):7863-7. PubMed ID: 12097599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.
    Center RJ; Schuck P; Leapman RD; Arthur LO; Earl PL; Moss B; Lebowitz J
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14877-82. PubMed ID: 11752436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.
    Center RJ; Lebowitz J; Leapman RD; Moss B
    J Virol; 2004 Mar; 78(5):2265-76. PubMed ID: 14963123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions.
    Arakelyan A; Fitzgerald W; King DF; Rogers P; Cheeseman HM; Grivel JC; Shattock RJ; Margolis L
    Sci Rep; 2017 Apr; 7(1):948. PubMed ID: 28424455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
    Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
    Johnson JE; Rodgers W; Rose JK
    Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Earl PL; Doms RW; Moss B
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):648-52. PubMed ID: 2300552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
    Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
    J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions.
    Zhu P; Chertova E; Bess J; Lifson JD; Arthur LO; Liu J; Taylor KA; Roux KH
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15812-7. PubMed ID: 14668432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
    Martin G; Beauséjour Y; Thibodeau J; Tremblay MJ
    Virology; 2005 May; 335(2):286-90. PubMed ID: 15840527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
    Wang BZ; Liu W; Kang SM; Alam M; Huang C; Ye L; Sun Y; Li Y; Kothe DL; Pushko P; Dokland T; Haynes BF; Smith G; Hahn BH; Compans RW
    J Virol; 2007 Oct; 81(20):10869-78. PubMed ID: 17670815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.